Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

Thursday, April 18, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. is set to host its first quarter 2024 earnings conference call and webcast on May 2, 2024, at 8:00 a.m. Eastern Time. The session aims to discuss the company's financial and operating results. Participants are encouraged to register online in advance to avoid delays, and a replay will be made available shortly after the event. Lantheus has a strong history in the radiopharmaceutical sector, contributing to improved patient care.
Price reaction · baseline $61.48 (2024-04-17 close) · hit after-hours · clean, no other LNTH news in the window
day 0 close · peak
+1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is hosting a conference call to discuss positive financial results.
  • The company is a leader in radiopharmaceuticals, enhancing patient outcomes.
  • The announcement indicates transparency and communication with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024, to discuss its financial and operating results for the first quarter of 2024.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.

Frequently Asked Questions

When is Lantheus' conference call scheduled?

The conference call is set for May 2, 2024, at 8:00 a.m. ET.

How can I access the Lantheus conference call?

Participants can register online at their investor calendar page.

Is there a replay available for the conference call?

Yes, a replay will be available about two hours after the webcast.

How long will the conference call replay be archived?

The replay will be archived for at least 30 days.

What does Lantheus specialize in?

Lantheus focuses on radiopharmaceutical solutions for better patient outcomes.

ShareAdd on Google
Tags: LNTH Viatris Investor Conferences Healthcare Lantheus earnings call radiopharmaceuticals financial results
Last updated: Apr 18, 2024

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+48%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →